Effectiveness of non surgical multidisciplinary therapy for rupture of pancreatic pseudocyst with intraabdominal bleeding and pancreatic fistula

Introdução: O tumor sólido pseudopapilar do pâncreas ou Tumor de Frantz, é uma neoplasia rara, que acomete preferencialmente mulheres jovens e apresenta bom prognóstico, com baixas taxas de mortalidade. Relato de Caso: O presente trabalho apresenta um caso de uma paciente da Santa Casa de São Paulo, com Tumor de Frantz, seu diagnóstico, tratamento e complicações pós pancreatectomia.Descritores: Pâncreas, Neoplasias pancreáticas, Carcinoma papilar, Pseudocisto pancreático, Fístula pancreáticaAbstractIntroduction: The solid pseudopapillary tumor, or Frantz’s tumor, is a rare neoplasm that occurs mainly in young women and have a good prognosis, with a low mortality rate. Case report: This study aims to describe the diagnosis, treatment and post pancreatectomy complications of a Frantz’s tumor case in Santa Casa of São Paulo.Keywords: Pancreas, Pancreatic neoplasms; Carcinoma, pappilary; Pancreatic pseudocyst; Pancreatic fistula

Download Full-text

Effectiveness of multidisciplinary therapy for pancreatic fistula complicated with pericardial effusion

Progress of Digestive Endoscopy ◽

10.11641/pde.90.1_162 ◽

2017 ◽

Vol 90 (1) ◽

pp. 162-163

Author(s):

Yurie Yamamoto ◽

Naoki Okano ◽

Aya Hojo ◽

Hiroki Nakagawa ◽

Saki Iwasaki ◽

...

Keyword(s):

Pericardial Effusion ◽

Pancreatic Fistula ◽

Multidisciplinary Therapy

Download Full-text

Nonsurgical Therapies for Hepatocellular and Cholangiocellular Carcinoma

Swiss Surgery ◽

10.1024/1023-9332.5.3.116 ◽

1999 ◽

Vol 5 (3) ◽

pp. 116-121 ◽

Cited By ~ 1

Author(s):

Schmassmann

Keyword(s):

Current Trend ◽

Percutaneous Ethanol Injection ◽

Cholangiocellular Carcinoma ◽

Multidisciplinary Therapy ◽

Term Survival ◽

Ethanol Injection ◽

First Choice ◽

Tumor Stages ◽

Choice Of Treatment ◽

Advanced Stages

Surgical resection is the first choice of treatment for patients with hepatocellular (HCC) and cholangiocellular carcinomas. Prolongation of survival is, however, the only realistic goal for most patients, which can be often achieved by nonsurgical therapies. Inoperable patients with large or multiple HCCs are usually treated with transarterial chemoembolization (TACE) with lipiodol in combination with a chemotherapeutic drug and gelfoam. Three-year survival depends on the stage of the disease and is about 20%. Patients with earlier tumor stages (one or two tumor nodules less than 3cm in size) are suitable for treatment with percutaneous ethanol injection (PEI) alone or in combination with TACE. Several studies have shown that in these early stages, the 3-year survival rate is approximately 55%-70% in the actively treated patients which is significantly higher than in untreated patients. In advanced stages of the disease, TACE and PEI have no effect on survival and should not be performed. Some of these patients have been successfully treated with octreotide. Patients with inoperable cholangiocellular carcinoma are treated by endoscopic or percutaneous stent placement. If stenting does not achieve adequate biliary drainage, multidisciplinary therapy including internal / external radiotherapy or photodynamic therapy should be considered in patients with potential long-term survival. In conclusion, nonresectional therapies play an essential role in the therapy of inoperable hepato- and cholangiocellular carcinomas as they lead to satisfactory survival. Multidisciplinary therapy appears to be the current trend of management.

Download Full-text